CARS Response to COVID-19
Posted: March 17, 2020

The Canadian Association of Radiopharmaceutical Scientists (CARS) is closely monitoring the global developments related to the COVID-19 and potential challenges this will have on the field of radiopharmaceutical preparation and manufacturing.

To our knowledge, as of today no disruption in the regular operations in manufacturing of radiopharmaceuticals is reported.

Please read the full message of CARS President CARS_COVID19 response

Join our forum to follow our discussions regarding the latest updates, how the community responds to the unprecedented situation.



Join us as a member

Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.